UPXI: Upexi, Inc. Stock

by  •  • Comments Off on UPXI: Upexi, Inc. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 16.96
Enterprise Value ($M) 24.09
Book Value ($M) 1.85
Book Value / Share 1.29
Price / Book 9.17
NCAV ($M) -9.25
NCAV / Share -6.47
Price / NCAV -1.83

Profitability (mra)
Return on Invested Capital (ROIC) -2.01
Return on Assets (ROA) -0.36
Return on Equity (ROE) -0.88

Liquidity (mrq)
Quick Ratio 0.24
Current Ratio 0.37

Balance Sheet (mrq) ($M)
Current Assets 3.97
Assets 15.07
Liabilities 13.22
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-01 13G Novogratz Michael 5.86
04-30 13G GSR Growth Investments LP 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-04-22 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1
2025-02-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-12-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-12-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-07-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-05 37,141 294,015 12.63
2025-06-04 70,381 237,667 29.61
2025-06-03 43,175 165,881 26.03
2025-06-02 61,478 266,337 23.08

(click for more detail)

Similar Companies
TTNP – Titan Pharmaceuticals, Inc. UNCY – Unicycive Therapeutics, Inc.
UPC – Universe Pharmaceuticals INC VERU – Veru Inc.
VIVS – VivoSim Labs, Inc.


Financial data and stock pages provided by
Fintel.io